Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-29

FDA Approved: PLEGRIDY PEN — Supplemental Application (Biogen Inc.)

View source ↗

Summary

The FDA approved Biogen's supplemental application for the PLEGRIDY PEN (peginterferon beta-1a), a pen-delivery device for administering peginterferon beta-1a. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PLEGRIDY PEN (Peginterferon beta-1a)

Snippet

SUPPL AP for PLEGRIDY PEN (PEGINTERFERON BETA-1A)